Indivior PLC | Small-cap | Healthcare
$14.66
-0.54%
| Indivior PLC Stock Comparison:
Indivior PLC vs ZoetisIndivior PLC vs Haleon Plc - ADRIndivior PLC vs SupernusIndivior PLC vs Bausch HealthIndivior PLC vs Ani PharmaceuticalsIndivior PLC vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 1.2B
Gross Profit 957.0M 80.56%
Operating Income 228.0M 19.19%
Net Income 3.0M 0.25%
EPS (Diluted) $0.02

Balance Sheet Metrics

Total Assets 1.3B
Total Liabilities 1.7B
Shareholders Equity -348.0M

Cash Flow Metrics

Operating Cash Flow 373.0M
Free Cash Flow 5.0M

Revenue & Profitability Trend

Indivior PLC Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 1.2B 1.1B 901.0M 791.0M 647.0M
Cost of Goods Sold 231.0M 186.0M 159.0M 127.0M 97.0M
Gross Profit 957.0M 907.0M 742.0M 664.0M 550.0M
Research & Development 107.0M 106.0M 72.0M 52.0M 40.0M
Selling, General & Administrative 618.0M 811.0M 763.0M 431.0M 649.0M
Other Operating Expenses 4.0M -2.0M -2.0M 0 17.0M
Total Operating Expenses 729.0M 915.0M 833.0M 483.0M 706.0M
Operating Income 228.0M -8.0M -91.0M 181.0M -156.0M
Pre-tax Income 14.0M 1.0M -95.0M 190.0M -173.0M
Income Tax 11.0M -1.0M -42.0M -15.0M -25.0M
Net Income 3.0M 2.0M -53.0M 205.0M -148.0M
EPS (Diluted) $0.02 $0.01 -$0.38 $1.35 -$1.00

Income Statement Trend

Indivior PLC Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 839.0M 1.3B 1.3B 1.4B 1.2B
Non-Current Assets 481.0M 691.0M 510.0M 388.0M 344.0M
Total Assets 1.3B 2.0B 1.8B 1.8B 1.5B
Liabilities
Current Liabilities 939.0M 1.3B 1.0B 804.0M 599.0M
Non-Current Liabilities 728.0M 649.0M 699.0M 825.0M 850.0M
Total Liabilities 1.7B 2.0B 1.7B 1.6B 1.4B
Equity
Total Shareholders Equity -348.0M 0 51.0M 203.0M 82.0M

Balance Sheet Composition

Indivior PLC Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 2.0M -4.0M -85.0M 213.0M -156.0M
Operating Cash Flow 373.0M -451.0M -43.0M 212.0M -193.0M
Investing Activities
Capital Expenditures -29.0M -8.0M -5.0M -4.0M -4.0M
Investing Cash Flow 70.0M -53.0M -223.0M -4.0M -4.0M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow -102.0M -41.0M -91.0M -86.0M -3.0M
Free Cash Flow 5.0M -368.0M -10.0M 319.0M -197.0M

Cash Flow Trend

Indivior PLC Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 530.50
Forward P/E 13.09
Price to Book -6.04
Price to Sales 1.49
PEG Ratio 13.09

Profitability Ratios

Profit Margin -5.30%
Operating Margin 25.56%
Return on Equity -0.57%
Return on Assets 12.60%

Financial Health

Current Ratio 0.88
Debt to Equity -1.29
Beta 0.25

Per Share Data

EPS (TTM) -$0.05
Book Value per Share -$2.28
Revenue per Share $9.05

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
indv 1.7B 530.50 -6.04 -0.57% -5.30% -1.29
Zoetis 70.3B 28.34 15.12 52.09% 27.12% 145.63
Haleon Plc - ADR 47.2B 25.01 5.88 8.95% 12.84% 63.41
Supernus 1.8B 28.53 1.72 6.32% 9.27% 3.13
Bausch Health 2.3B -47.00 -9.23 14.29% -0.41% -89.63
Ani Pharmaceuticals 1.4B 51.63 3.16 -4.57% -3.12% 142.03

Financial data is updated regularly. All figures are in the company's reporting currency.